סינרייז

Kraj: Izrael

Język: hebrajski

Źródło: Ministry of Health

Składnik aktywny:

C - 1 ESTERASE INHIBITOR HUMAN 500 UNITS

Dostępny od:

NEOPHARM CURE (2005) LTD

Kod ATC:

B02AB03

Forma farmaceutyczna:

LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION

Droga podania:

I.V

Wyprodukowano przez:

SANQUIN BLOOD SUPPLY FOUNDATION, THE NETHERLANDS

Grupa terapeutyczna:

C1-INHIBITOR

Wskazania:

Treatment and pre-procedure prevention of angioedema attacks in adults and adolescents with hereditary angioedema (HAE). Routine prevention of angioedema attacks in adults and adolescents with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.

Data autoryzacji:

2013-08-01